Specific and nonspecific binding of drug eluted from a half-embedded stent in presence of atherosclerotic plaque

Comput Methods Biomech Biomed Engin. 2022 Jun;25(8):922-935. doi: 10.1080/10255842.2021.1986813. Epub 2021 Oct 7.

Abstract

This study is dealt with the two-phase binding (specific and nonspecific) of drug eluted from a half- embedded drug-eluting stent in presence of atherosclerotic plaque. The specific binding due to the interaction of drug molecules with specific receptors and nonspecific binding caused by the trapping of drug in the extra-cellular matrix have been paid due attention. An idealised wall consisting of a plaque and a healthy tissue region has been considered. Moreover, a Dirichlet release condition is imposed on the strut surface. In this investigation, a two-dimensional model governing drug transport and its two-phase binding in cylindrical polar coordinate system has been solved numerically by a finite-difference method. Our simulation predicts that plaque behaves like a physical barrier in two types of the binding process and there is an inverse relationship between bound drug concentration and plaque thickness. Simulations show that a single peak profile of drug is noted when the struts are situated one-strut radius apart and as the inter-strut distance increases, the peak concentration falls and distinct peak profiles over each strut are visualised. The model also reveals that in the region downstream of a strut, the concentration of both bound drug forms in the plaque and healthy regions increases, and eventually, the saturation length of binding sites increases. Predicted results show for smaller Damköhler number, the rapid saturation of binding sites takes place and the stent having thinner strut may perform well in terms of effectiveness as well as efficacy in the stent-based delivery.

Keywords: Half-embedded DES; atherosclerotic plaque; nonlinear saturable reversible chemical reaction; nonspecific binding; specific binding.

MeSH terms

  • Coronary Vessels
  • Drug-Eluting Stents*
  • Humans
  • Pharmaceutical Preparations
  • Plaque, Atherosclerotic* / drug therapy
  • Prosthesis Design
  • Stents
  • Tomography, Optical Coherence / methods

Substances

  • Pharmaceutical Preparations